Airna’s series A to bring lead project into clinic ... - BioWorld
Aug 2, 2024 · Airna Corp. Inc., of Cambridge, Mass., announced it has closed an oversubscribed $60 million financing round, bringing its total series A funding to $90 million. Airna’s series A to …
OFF
Airna’s Series A To Bring Lead Project Into Clinic ... - BioWorld
1 week from now
Aug 2, 2024 · Airna Corp. Inc., of Cambridge, Mass., announced it has closed an oversubscribed $60 million financing round, bringing its total series A funding to $90 million. Airna’s series A to …
bioworld.com
OFF
AIRNA Raises Oversubscribed $60 Million Financing To
1 week from now
Jul 31, 2024 · The proceeds from the Series A financing will be used to advance AIRNA’s lead product candidate into clinical trials and further develop AIRNA’s broad pipeline.
businesswire.com
OFF
AIRNA Raises $90 Million Series A To Bring RNA Editing Therapies …
1 week from now
Aug 1, 2024 · AIRNA plans to bring RNA editing therapies to the clinic starting with a treatment for the genetic disease alpha-1 antitrypsin deficiency. German American RNA editing biotech …
biopharma-reporter.com
OFF
Series A - AIRNA - 2024-07-31 - Crunchbase Funding Round Profile
1 week from now
Jul 31, 2024 · AIRNA raised $60000000 on 2024-07-31 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ... BioWorld Financial …
crunchbase.com
OFF
AIRNA Raises $90 Million To Make RNA-editing Drugs
1 week from now
Jul 31, 2024 · Pharmaceutical start-up AIRNA has raised $90 million in an oversubscribed series A financing round. The firm aims to produce drugs that edit RNA transcripts in the body. ...
acs.org
OFF
AIRNA Raises Oversubscribed $60 Million Financing To Advance …
1 week from now
Jul 31, 2024 · Cambridge, MA, USA and Tübingen, Germany, July 31, 2024 – AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and …
airna.com
OFF
Four Biotech Startups Reel In $238M In Financing To Ramp Up For ...
1 week from now
Aug 22, 2021 · Eight months after launch, Vigil Neurosciences announced this week a $90 million Series B round of funding as the company prepares to bring its lead program into the clinic. …
medcitynews.com
OFF
Fierce Biotech Fundraising Tracker '23
1 week from now
Dec 20, 2023 · Sudo Biosciences has secured $116 million to advance programs in multiple sclerosis and psoriasis into the clinic. The fresh nine-figure haul is a far jump from Sudo’s $37 …
fiercebiotech.com
OFF
Kivu Bioscience Closes Series A Financing To Advance ADC Pipeline …
1 week from now
Oct 29, 2024 · Kivu Bioscience has closed a $92 million series A financing to its advance its topoisomerase I inhibitor-based antibody-drug conjugate (ADC) pipeline into the clinic. Kivu …
bioworld.com
OFF
Ratio Raises Series B To Advance Radiotherapeutic Into Clinic
1 week from now
Jan 19, 2024 · Ratio Therapeutics Inc. has closed a $50 million series B financing to expand application of its proprietary technology ... Ratio raises series B to advance radiotherapeutic …
bioworld.com
OFF
Series A - AIRNA - 2023-09-19 - Crunchbase Funding Round Profile
1 week from now
Sep 19, 2023 · AIRNA raised $30000000 on 2023-09-19 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …
crunchbase.com
OFF
Lilly-backed Superluminal Speeds Toward The Clinic With $120M
1 week from now
Sep 9, 2024 · Lilly-backed Superluminal raises $120M series A to bring membrane receptor drugs into the clinic. ... Superluminal will use the cash to advance its lead asset into the clinic.
fiercebiotech.com
OFF
Accession Therapeutics Preparing To Advance Lead Candidate Into …
1 week from now
Apr 29, 2024 · Accession Therapeutics Ltd. has raised £25 million (US$31.3 million) to fund it through the generation of the first clinical data for its lead product, TROCEPT-01 (ATTR-01), …
bioworld.com
OFF
Abalos Adds $38M In Series A Extension To Take Virotherapy Into …
1 week from now
Oct 14, 2021 · DUBLIN – Abalos Therapeutics GmbH raised €32.5 million (US$37.6 million) in a series A extension, taking the total raise to €43 million, enough to enable the company to …
bioworld.com
OFF
Iksuda Advancing Lead ADC To The Clinic With $47M Series A Financing
1 week from now
LONDON – Iksuda Therapeutics Ltd. sealed its transition from technology licensing company to antibody-drug conjugate (ADC) development specialist, closing a $47 million series A …
bioworld.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
